Veloxity Labs, a bioanalytical contract research organization (CRO) specializing in accelerating therapeutic development, is proud to announce a partnership with Aplos Analytics. This collaboration ...

Drug developer GSK is vacating its 635,000-square-foot life sciences lab in Rockville, Maryland, where it was the sole tenant ...

For decades, scientists across the globe have investigated methods to accurately measure drug permeability across the blood-brain barrier, a compact layer of cells that protect the brain from ...

Under the new proposal, like the previous one, members of the Sackler family would also give up ownership of Purdue. They've already stepped down from the company's board and have not taken ...

Farm Fresh, meanwhile, tries to rebound from a recent setback to Chery Tiggo as the Foxies face the struggling Galeries Tower Highrisers at 6 p.m. The Crossovers bolstered their campaign with a ...

Sherma Ellis-Daal, Brand Director at Pharmapack shares her views on the pharmaceutical packaging sector, the latest industry trends that were witnessed at Pharmapack Europe, Europe's leading packaging ...

Purdue Pharma and owners to pay $7.4 billion in settlement of lawsuits over the toll of OxyContin By Geoff Mulvihill/The Associated Press • January 28, 2025 • 5 mins to read ...

There is little scientific evidence to support its use for these conditions, however, gelatin has many pharmaceutical ... a double-blind crossover study. Nutrients. 2017;9(7):735.

Rob Cross clinched his fifth World Series title with an 8-5 triumph over Stephen Bunting in the Dutch Masters final. Earlier this month, Bunting had secured the Bahrain Masters and was vying for ...

Members of the Sackler family who own OxyContin maker Purdue Pharma, and the company itself, agreed to pay up to $7.4 billion to settle lawsuits over the toll of the powerful prescription ...

Ascendis Pharma A/S has a 1-year low of $111.09 and a 1-year high of $161.00. The company has a market cap of $7.78 billion, a price-to-earnings ratio of -15.87 and a beta of 0.65.

Members of the family who own OxyContin maker Purdue Pharma, and the company itself, agreed to pay up to $7.4 billion in a new settlement to lawsuits over the toll of the powerful prescription ...